glutathione in ovarian cancer a double-edged sword Role of SLC7A11/xCT Frontiers | Metabolic reprogramming of
Frontiers Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy Frontiers Targeting ferroptosis: a promising avenue for ovarian cancer treatment Frontiers The versatile utility of cysteine as a target for cancer treatment FerroptosisThe Double Edged Sword in Cancer: Mechanisms of Tumor Suppression Resistance and Therapeutic Manipulation Reactive oxygen species: Janus faced molecules in the era of modern cancer therapy Journal for ImmunoTherapy of Cancer
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




